Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for t...
Leadership
Christopher T. Giordano
CEO, President & Director
Thomas A. McGauley
Principal Financial Officer & Principal Accounting Officer
Stuart Rich M.D.
Chief Medical Officer & Director
Thomas R. Staab II, CPA
Chief Financial Officer
Doug Randall
Chief Business Officer
Douglas Hay Ph.D.
Executive Vice President of Regulatory Affairs
Timothy G. Healey M.B.A.
Chief Commercial Officer
So-Young Kim M.D.
Executive Vice President of Clinical Development & Strategy
